Home
>
National Drug Code (NDC)
>
Chloroquine phosphate
Chloroquine phosphate - 63304-460-50 - (Chloroquine phosphate)
Drug Information of Chloroquine phosphate
| Product NDC: | 63304-460 |
| Proprietary Name: | Chloroquine phosphate |
| Non Proprietary Name: | Chloroquine phosphate |
| Active Ingredient(s): | 250 mg/1 & nbsp; Chloroquine phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Chloroquine phosphate
| Product NDC: | 63304-460 |
| Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090610 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110315 |
Package Information of Chloroquine phosphate
| Package NDC: | 63304-460-50 |
| Package Description: | 50 TABLET, FILM COATED in 1 BAG (63304-460-50) |
NDC Information of Chloroquine phosphate
| NDC Code | 63304-460-50 |
| Proprietary Name | Chloroquine phosphate |
| Package Description | 50 TABLET, FILM COATED in 1 BAG (63304-460-50) |
| Product NDC | 63304-460 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Chloroquine phosphate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20110315 |
| Marketing Category Name | ANDA |
| Labeler Name | Ranbaxy Pharmaceuticals Inc. |
| Substance Name | CHLOROQUINE PHOSPHATE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antimalarial [EPC] |
